Global Nuclear Medicine & Radiopharmaceutic Industry Research Report, Growth Trends and Competitive Analysis 2022-2028
Table of Contents1 Report Overview
1.1 Research Scope
1.2 Market Segment by Type
1.2.1 Global Nuclear Medicine & Radiopharmaceutic Market Size Growth Rate by Type (2017 VS 2021 VS 2028)
1.2.2 Tc-99
1.2.3 I-123/131
1.2.4 In-111
1.2.5 Xe-133
1.2.6 Th-201
1.2.7 Ga-67
1.2.8 Other
1.3 Market Segment by Application
1.3.1 Global Nuclear Medicine & Radiopharmaceutic Market Share by Application (2017 VS 2021 VS 2028)
1.3.2 Diagnostic
1.3.3 Therapeutic
1.4 Study Objectives
1.5 Years Considered
2 Market Perspective
2.1 Global Nuclear Medicine & Radiopharmaceutic Market Size (2017-2028)
2.1.1 Global Nuclear Medicine & Radiopharmaceutic Revenue (2017-2028)
2.1.2 Global Nuclear Medicine & Radiopharmaceutic Sales (2017-2028)
2.2 Global Nuclear Medicine & Radiopharmaceutic Market Size across Key Geographies Worldwide: 2017 VS 2021 VS 2028
2.2.1 Global Nuclear Medicine & Radiopharmaceutic Sales by Regions (2017-2022)
2.2.2 Global Nuclear Medicine & Radiopharmaceutic Revenue by Regions (2017-2022)
2.3 Global Nuclear Medicine & Radiopharmaceutic Market Size Forecast by Region
2.3.1 Global Nuclear Medicine & Radiopharmaceutic Sales Forecast by Region (2023-2028)
2.3.2 Global Nuclear Medicine & Radiopharmaceutic Revenue Forecast by Region (2023-2028)
2.4 Global Top Nuclear Medicine & Radiopharmaceutic Regions (Countries) Ranking by Market Size
2.5 Nuclear Medicine & Radiopharmaceutic Market Dynamics
2.5.1 Nuclear Medicine & Radiopharmaceutic Market Trends
2.5.2 Nuclear Medicine & Radiopharmaceutic Market Drivers
2.5.3 Nuclear Medicine & Radiopharmaceutic Market Challenges
2.5.4 Nuclear Medicine & Radiopharmaceutic Market Restraints
3 Competitive Landscape by Manufacturers
3.1 Global Top Nuclear Medicine & Radiopharmaceutic Manufacturers by Sales (2017-2022)
3.1.1 Global Nuclear Medicine & Radiopharmaceutic Sales by Manufacturers (2017-2022)
3.1.2 Global Nuclear Medicine & Radiopharmaceutic Sales Market Share by Manufacturers (2017-2022)
3.1.3 Global 5 and 10 Largest Manufacturers by Nuclear Medicine & Radiopharmaceutic Sales in 2021
3.2 Global Top Manufacturers Nuclear Medicine & Radiopharmaceutic by Revenue
3.2.1 Global Nuclear Medicine & Radiopharmaceutic Revenue by Manufacturers (2017-2022)
3.2.2 Top Nuclear Medicine & Radiopharmaceutic Manufacturers Covered: Ranking by Revenue
3.2.3 Global Nuclear Medicine & Radiopharmaceutic Revenue Share by Manufacturers (2017-2022)
3.2.4 Global Nuclear Medicine & Radiopharmaceutic Market Concentration Ratio (CR5 and HHI)
3.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Nuclear Medicine & Radiopharmaceutic as of 2021)
3.4 Global Nuclear Medicine & Radiopharmaceutic Average Selling Price (ASP) by Manufacturers
3.5 Key Manufacturers Nuclear Medicine & Radiopharmaceutic Plants/Factories Distribution and Area Served
3.6 Date of Key Manufacturers Enter into Nuclear Medicine & Radiopharmaceutic Market
3.7 Key Manufacturers Nuclear Medicine & Radiopharmaceutic Product Offered
3.8 Mergers & Acquisitions, Expansion Plans
4 Global Nuclear Medicine & Radiopharmaceutic Market Size by Type
4.1 Global Nuclear Medicine & Radiopharmaceutic Historic Market Review by Type (2017-2022)
4.1.1 Global Nuclear Medicine & Radiopharmaceutic Sales Market Share by Type (2017-2022)
4.1.2 Global Nuclear Medicine & Radiopharmaceutic Revenue Market Share by Type (2017-2022)
4.1.3 Nuclear Medicine & Radiopharmaceutic Price by Type (2017-2022)
4.2 Global Nuclear Medicine & Radiopharmaceutic Market Estimates and Forecasts by Type (2023-2028)
4.2.1 Global Nuclear Medicine & Radiopharmaceutic Sales Forecast by Type (2023-2028)
4.2.2 Global Nuclear Medicine & Radiopharmaceutic Revenue Forecast by Type (2023-2028)
4.2.3 Nuclear Medicine & Radiopharmaceutic Price Forecast by Type (2023-2028)
5 Global Nuclear Medicine & Radiopharmaceutic Market Size by Application
5.1 Global Nuclear Medicine & Radiopharmaceutic Historic Market Review by Application (2017-2022)
5.1.1 Global Nuclear Medicine & Radiopharmaceutic Sales Market Share by Application (2017-2022)
5.1.2 Global Nuclear Medicine & Radiopharmaceutic Revenue Market Share by Application (2017-2022)
5.1.3 Nuclear Medicine & Radiopharmaceutic Price by Application (2017-2022)
5.2 Global Nuclear Medicine & Radiopharmaceutic Market Estimates and Forecasts by Application (2023-2028)
5.2.1 Global Nuclear Medicine & Radiopharmaceutic Sales Forecast by Application (2023-2028)
5.2.2 Global Nuclear Medicine & Radiopharmaceutic Revenue Forecast by Application (2023-2028)
5.2.3 Nuclear Medicine & Radiopharmaceutic Price Forecast by Application (2023-2028)
6 North America
6.1 North America Nuclear Medicine & Radiopharmaceutic Sales Breakdown by Company
6.1.1 North America Nuclear Medicine & Radiopharmaceutic Sales by Company (2017-2022)
6.1.2 North America Nuclear Medicine & Radiopharmaceutic Revenue by Company (2017-2022)
6.2 North America Nuclear Medicine & Radiopharmaceutic Market Size by Type
6.2.1 North America Nuclear Medicine & Radiopharmaceutic Sales by Type (2017-2028)
6.2.2 North America Nuclear Medicine & Radiopharmaceutic Revenue by Type (2017-2028)
6.3 North America Nuclear Medicine & Radiopharmaceutic Market Size by Application
6.3.1 North America Nuclear Medicine & Radiopharmaceutic Sales by Application (2017-2028)
6.3.2 North America Nuclear Medicine & Radiopharmaceutic Revenue by Application (2017-2028)
6.4 North America Nuclear Medicine & Radiopharmaceutic Market Size by Country
6.4.1 North America Nuclear Medicine & Radiopharmaceutic Sales by Country (2017-2028)
6.4.2 North America Nuclear Medicine & Radiopharmaceutic Revenue by Country (2017-2028)
6.4.3 U.S.
6.4.4 Canada
7 Europe
7.1 Europe Nuclear Medicine & Radiopharmaceutic Sales Breakdown by Company
7.1.1 Europe Nuclear Medicine & Radiopharmaceutic Sales by Company (2017-2022)
7.1.2 Europe Nuclear Medicine & Radiopharmaceutic Revenue by Company (2017-2022)
7.2 Europe Nuclear Medicine & Radiopharmaceutic Market Size by Type
7.2.1 Europe Nuclear Medicine & Radiopharmaceutic Sales by Type (2017-2028)
7.2.2 Europe Nuclear Medicine & Radiopharmaceutic Revenue by Type (2017-2028)
7.3 Europe Nuclear Medicine & Radiopharmaceutic Market Size by Application
7.3.1 Europe Nuclear Medicine & Radiopharmaceutic Sales by Application (2017-2028)
7.3.2 Europe Nuclear Medicine & Radiopharmaceutic Revenue by Application (2017-2028)
7.4 Europe Nuclear Medicine & Radiopharmaceutic Market Size by Country
7.4.1 Europe Nuclear Medicine & Radiopharmaceutic Sales by Country (2017-2028)
7.4.2 Europe Nuclear Medicine & Radiopharmaceutic Revenue by Country (2017-2028)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
8 Asia Pacific
8.1 Asia Pacific Nuclear Medicine & Radiopharmaceutic Sales Breakdown by Company
8.1.1 Asia Pacific Nuclear Medicine & Radiopharmaceutic Sales by Company (2017-2022)
8.1.2 Asia Pacific Nuclear Medicine & Radiopharmaceutic Revenue by Company (2017-2022)
8.2 Asia Pacific Nuclear Medicine & Radiopharmaceutic Market Size by Type
8.2.1 Asia Pacific Nuclear Medicine & Radiopharmaceutic Sales by Type (2017-2028)
8.2.2 Asia Pacific Nuclear Medicine & Radiopharmaceutic Revenue by Type (2017-2028)
8.3 Asia Pacific Nuclear Medicine & Radiopharmaceutic Market Size by Application
8.3.1 Asia Pacific Nuclear Medicine & Radiopharmaceutic Sales by Application (2017-2028)
8.3.2 Asia Pacific Nuclear Medicine & Radiopharmaceutic Revenue by Application (2017-2028)
8.4 Asia Pacific Nuclear Medicine & Radiopharmaceutic Market Size by Region
8.4.1 Asia Pacific Nuclear Medicine & Radiopharmaceutic Sales by Region
8.4.2 Asia Pacific Nuclear Medicine & Radiopharmaceutic Revenue by Region
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 India
8.4.7 Australia
8.4.8 China Taiwan
8.4.9 Indonesia
8.4.10 Thailand
8.4.11 Malaysia
9 Latin America
9.1 Latin America Nuclear Medicine & Radiopharmaceutic Sales Breakdown by Company
9.1.1 Latin America Nuclear Medicine & Radiopharmaceutic Sales by Company (2017-2022)
9.1.2 Latin America Nuclear Medicine & Radiopharmaceutic Revenue by Company (2017-2022)
9.2 Latin America Nuclear Medicine & Radiopharmaceutic Market Size by Type
9.2.1 Latin America Nuclear Medicine & Radiopharmaceutic Sales by Type (2017-2028)
9.2.2 Latin America Nuclear Medicine & Radiopharmaceutic Revenue by Type (2017-2028)
9.3 Latin America Nuclear Medicine & Radiopharmaceutic Market Size by Application
9.3.1 Latin America Nuclear Medicine & Radiopharmaceutic Sales by Application (2017-2028)
9.3.2 Latin America Nuclear Medicine & Radiopharmaceutic Revenue by Application (2017-2028)
9.4 Latin America Nuclear Medicine & Radiopharmaceutic Market Size by Country
9.4.1 Latin America Nuclear Medicine & Radiopharmaceutic Sales by Country (2017-2028)
9.4.2 Latin America Nuclear Medicine & Radiopharmaceutic Revenue by Country (2017-2028)
9.4.3 Mexico
9.4.4 Brazil
9.4.5 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Nuclear Medicine & Radiopharmaceutic Sales Breakdown by Company
10.1.1 Middle East and Africa Nuclear Medicine & Radiopharmaceutic Sales by Company (2017-2022)
10.1.2 Middle East and Africa Nuclear Medicine & Radiopharmaceutic Revenue by Company (2017-2022)
10.2 Middle East and Africa Nuclear Medicine & Radiopharmaceutic Market Size by Type
10.2.1 Middle East and Africa Nuclear Medicine & Radiopharmaceutic Sales by Type (2017-2028)
10.2.2 Middle East and Africa Nuclear Medicine & Radiopharmaceutic Revenue by Type (2017-2028)
10.3 Middle East and Africa Nuclear Medicine & Radiopharmaceutic Market Size by Application
10.3.1 Middle East and Africa Nuclear Medicine & Radiopharmaceutic Sales by Application (2017-2028)
10.3.2 Middle East and Africa Nuclear Medicine & Radiopharmaceutic Revenue by Application (2017-2028)
10.4 Middle East and Africa Nuclear Medicine & Radiopharmaceutic Market Size by Country
10.4.1 Middle East and Africa Nuclear Medicine & Radiopharmaceutic Sales by Country (2017-2028)
10.4.2 Middle East and Africa Nuclear Medicine & Radiopharmaceutic Revenue by Country (2017-2028)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Company Profiles
11.1 GE Healthcare
11.1.1 GE Healthcare Corporation Information
11.1.2 GE Healthcare Overview
11.1.3 GE Healthcare Nuclear Medicine & Radiopharmaceutic Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2017-2022)
11.1.4 GE Healthcare Nuclear Medicine & Radiopharmaceutic Products and Services
11.1.5 GE Healthcare Nuclear Medicine & Radiopharmaceutic SWOT Analysis
11.1.6 GE Healthcare Recent Developments
11.2 Bracco Imaging
11.2.1 Bracco Imaging Corporation Information
11.2.2 Bracco Imaging Overview
11.2.3 Bracco Imaging Nuclear Medicine & Radiopharmaceutic Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2017-2022)
11.2.4 Bracco Imaging Nuclear Medicine & Radiopharmaceutic Products and Services
11.2.5 Bracco Imaging Nuclear Medicine & Radiopharmaceutic SWOT Analysis
11.2.6 Bracco Imaging Recent Developments
11.3 Mallinckrodt
11.3.1 Mallinckrodt Corporation Information
11.3.2 Mallinckrodt Overview
11.3.3 Mallinckrodt Nuclear Medicine & Radiopharmaceutic Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2017-2022)
11.3.4 Mallinckrodt Nuclear Medicine & Radiopharmaceutic Products and Services
11.3.5 Mallinckrodt Nuclear Medicine & Radiopharmaceutic SWOT Analysis
11.3.6 Mallinckrodt Recent Developments
11.4 Lantheus Medical Imaging
11.4.1 Lantheus Medical Imaging Corporation Information
11.4.2 Lantheus Medical Imaging Overview
11.4.3 Lantheus Medical Imaging Nuclear Medicine & Radiopharmaceutic Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2017-2022)
11.4.4 Lantheus Medical Imaging Nuclear Medicine & Radiopharmaceutic Products and Services
11.4.5 Lantheus Medical Imaging Nuclear Medicine & Radiopharmaceutic SWOT Analysis
11.4.6 Lantheus Medical Imaging Recent Developments
11.5 Bayer
11.5.1 Bayer Corporation Information
11.5.2 Bayer Overview
11.5.3 Bayer Nuclear Medicine & Radiopharmaceutic Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2017-2022)
11.5.4 Bayer Nuclear Medicine & Radiopharmaceutic Products and Services
11.5.5 Bayer Nuclear Medicine & Radiopharmaceutic SWOT Analysis
11.5.6 Bayer Recent Developments
11.6 Jubilant Pharma
11.6.1 Jubilant Pharma Corporation Information
11.6.2 Jubilant Pharma Overview
11.6.3 Jubilant Pharma Nuclear Medicine & Radiopharmaceutic Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2017-2022)
11.6.4 Jubilant Pharma Nuclear Medicine & Radiopharmaceutic Products and Services
11.6.5 Jubilant Pharma Nuclear Medicine & Radiopharmaceutic SWOT Analysis
11.6.6 Jubilant Pharma Recent Developments
11.7 Nordion
11.7.1 Nordion Corporation Information
11.7.2 Nordion Overview
11.7.3 Nordion Nuclear Medicine & Radiopharmaceutic Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2017-2022)
11.7.4 Nordion Nuclear Medicine & Radiopharmaceutic Products and Services
11.7.5 Nordion Nuclear Medicine & Radiopharmaceutic SWOT Analysis
11.7.6 Nordion Recent Developments
11.8 Eli Lilly
11.8.1 Eli Lilly Corporation Information
11.8.2 Eli Lilly Overview
11.8.3 Eli Lilly Nuclear Medicine & Radiopharmaceutic Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2017-2022)
11.8.4 Eli Lilly Nuclear Medicine & Radiopharmaceutic Products and Services
11.8.5 Eli Lilly Nuclear Medicine & Radiopharmaceutic SWOT Analysis
11.8.6 Eli Lilly Recent Developments
11.9 SIEMENS
11.9.1 SIEMENS Corporation Information
11.9.2 SIEMENS Overview
11.9.3 SIEMENS Nuclear Medicine & Radiopharmaceutic Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2017-2022)
11.9.4 SIEMENS Nuclear Medicine & Radiopharmaceutic Products and Services
11.9.5 SIEMENS Nuclear Medicine & Radiopharmaceutic SWOT Analysis
11.9.6 SIEMENS Recent Developments
11.10 China Isotope & Radiation
11.10.1 China Isotope & Radiation Corporation Information
11.10.2 China Isotope & Radiation Overview
11.10.3 China Isotope & Radiation Nuclear Medicine & Radiopharmaceutic Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2017-2022)
11.10.4 China Isotope & Radiation Nuclear Medicine & Radiopharmaceutic Products and Services
11.10.5 China Isotope & Radiation Nuclear Medicine & Radiopharmaceutic SWOT Analysis
11.10.6 China Isotope & Radiation Recent Developments
11.11 Yantai Dongcheng Biochemicals
11.11.1 Yantai Dongcheng Biochemicals Corporation Information
11.11.2 Yantai Dongcheng Biochemicals Overview
11.11.3 Yantai Dongcheng Biochemicals Nuclear Medicine & Radiopharmaceutic Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2017-2022)
11.11.4 Yantai Dongcheng Biochemicals Nuclear Medicine & Radiopharmaceutic Products and Services
11.11.5 Yantai Dongcheng Biochemicals Recent Developments
12 Value Chain and Sales Channels Analysis
12.1 Nuclear Medicine & Radiopharmaceutic Value Chain Analysis
12.2 Nuclear Medicine & Radiopharmaceutic Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Nuclear Medicine & Radiopharmaceutic Production Mode & Process
12.4 Nuclear Medicine & Radiopharmaceutic Sales and Marketing
12.4.1 Nuclear Medicine & Radiopharmaceutic Sales Channels
12.4.2 Nuclear Medicine & Radiopharmaceutic Distributors
12.5 Nuclear Medicine & Radiopharmaceutic Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer
List of TablesTable 1. Global Nuclear Medicine & Radiopharmaceutic Market Size Growth Rate by Type, 2017 VS 2021 VS 2028 (US$ Million)
Table 2. Major Manufacturers of Tc-99
Table 3. Major Manufacturers of I-123/131
Table 4. Major Manufacturers of In-111
Table 5. Major Manufacturers of Xe-133
Table 6. Major Manufacturers of Th-201
Table 7. Major Manufacturers of Ga-67
Table 8. Major Manufacturers of Other
Table 9. Global Nuclear Medicine & Radiopharmaceutic Market Size Growth Rate by Application, 2017 VS 2021 VS 2028 (US$ Million)
Table 10. Global Nuclear Medicine & Radiopharmaceutic Market Size (US$ Million) by Region: 2017 VS 2021 VS 2028
Table 11. Global Nuclear Medicine & Radiopharmaceutic Sales by Region (2017-2022) & (Kiloton)
Table 12. Global Nuclear Medicine & Radiopharmaceutic Sales Market Share by Region (2017-2022)
Table 13. Global Nuclear Medicine & Radiopharmaceutic Revenue by Region (2017-2022) & (US$ Million)
Table 14. Global Nuclear Medicine & Radiopharmaceutic Revenue Market Share by Region (2017-2022)
Table 15. Global Nuclear Medicine & Radiopharmaceutic Sales Forecast by Region (2023-2028) & (Kiloton)
Table 16. Global Nuclear Medicine & Radiopharmaceutic Sales Market Share Forecast by Region (2023-2028)
Table 17. Global Nuclear Medicine & Radiopharmaceutic Revenue Forecast by Region (2023-2028) & (US$ Million)
Table 18. Global Nuclear Medicine & Radiopharmaceutic Revenue Market Share Forecast by Region (2023-2028)
Table 19. Top Nuclear Medicine & Radiopharmaceutic Regions (Countries) Ranking by Market Size (US$ Million) in 2021
Table 20. Nuclear Medicine & Radiopharmaceutic Market Trends
Table 21. Nuclear Medicine & Radiopharmaceutic Market Drivers
Table 22. Nuclear Medicine & Radiopharmaceutic Market Challenges
Table 23. Nuclear Medicine & Radiopharmaceutic Market Restraints
Table 24. Global Nuclear Medicine & Radiopharmaceutic Sales by Manufacturers (2017-2022) & (Kiloton)
Table 25. Global Nuclear Medicine & Radiopharmaceutic Sales Share by Manufacturers (2017-2022)
Table 26. Global Nuclear Medicine & Radiopharmaceutic Revenue by Manufacturers (2017-2022) & (US$ Million)
Table 27. Ranking of Global Top Nuclear Medicine & Radiopharmaceutic Manufacturers by Revenue (US$ Million) in 2021
Table 28. Nuclear Medicine & Radiopharmaceutic Revenue Share by Manufacturers (2017-2022)
Table 29. Global Nuclear Medicine & Radiopharmaceutic Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 30. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Nuclear Medicine & Radiopharmaceutic as of 2021)
Table 31. Key Manufacturers Nuclear Medicine & Radiopharmaceutic Average Selling Price (ASP) & (2017-2022) & (US$/Ton)
Table 32. Key Manufacturers Nuclear Medicine & Radiopharmaceutic Plants/Factories Distribution
Table 33. Key Manufacturers Nuclear Medicine & Radiopharmaceutic Area Served
Table 34. Date of Key Manufacturers Enter into Nuclear Medicine & Radiopharmaceutic Market
Table 35. Key Manufacturers Nuclear Medicine & Radiopharmaceutic Product Type
Table 36. Mergers & Acquisitions, Expansion Plans
Table 37. Global Nuclear Medicine & Radiopharmaceutic Sales (Kiloton) by Type (2017-2022)
Table 38. Global Nuclear Medicine & Radiopharmaceutic Sales Share by Type (2017-2022)
Table 39. Global Nuclear Medicine & Radiopharmaceutic Revenue (US$ Million) Market Share by Type (2017-2022)
Table 40. Global Nuclear Medicine & Radiopharmaceutic Price (Kiloton) by Type (2017-2022)
Table 41. Global Nuclear Medicine & Radiopharmaceutic Sales (Kiloton) by Type (2023-2028)
Table 42. Global Nuclear Medicine & Radiopharmaceutic Sales Share by Type (2023-2028)
Table 43. Global Nuclear Medicine & Radiopharmaceutic Revenue (US$ Million) Market Share by Type (2023-2028)
Table 44. Global Nuclear Medicine & Radiopharmaceutic Revenue Share by Type (2023-2028)
Table 45. Global Nuclear Medicine & Radiopharmaceutic Price (Kiloton) by Type (2023-2028)
Table 46. Global Nuclear Medicine & Radiopharmaceutic Sales (Kiloton) by Application (2017-2022)
Table 47. Global Nuclear Medicine & Radiopharmaceutic Sales Share by Application (2017-2022)
Table 48. Global Nuclear Medicine & Radiopharmaceutic Revenue (US$ Million) Market Share by Application (2017-2022)
Table 49. Global Nuclear Medicine & Radiopharmaceutic Price (Kiloton) by Application (2017-2022)
Table 50. Global Nuclear Medicine & Radiopharmaceutic Sales (Kiloton) by Application (2023-2028)
Table 51. Global Nuclear Medicine & Radiopharmaceutic Sales Share by Application (2023-2028)
Table 52. Global Nuclear Medicine & Radiopharmaceutic Revenue (US$ Million) Market Share by Application (2023-2028)
Table 53. Global Nuclear Medicine & Radiopharmaceutic Revenue Share by Application (2023-2028)
Table 54. Global Nuclear Medicine & Radiopharmaceutic Price (Kiloton) by Application (2023-2028)
Table 55. North America Nuclear Medicine & Radiopharmaceutic Sales by Company (2017-2022) & (Kiloton)
Table 56. North America Nuclear Medicine & Radiopharmaceutic Sales Market Share by Company (2017-2022)
Table 57. North America Nuclear Medicine & Radiopharmaceutic Revenue by Company (2017-2022) & (US$ Million)
Table 58. North America Nuclear Medicine & Radiopharmaceutic Revenue Market Share by Company (2017-2022)
Table 59. North America Nuclear Medicine & Radiopharmaceutic Sales by Type (2017-2022) & (Kiloton)
Table 60. North America Nuclear Medicine & Radiopharmaceutic Sales by Type (2023-2028) & (Kiloton)
Table 61. North America Nuclear Medicine & Radiopharmaceutic Revenue by Type (2017-2022) & (US$ Million)
Table 62. North America Nuclear Medicine & Radiopharmaceutic Revenue by Type (2023-2028) & (US$ Million)
Table 63. North America Nuclear Medicine & Radiopharmaceutic Sales by Application (2017-2022) & (Kiloton)
Table 64. North America Nuclear Medicine & Radiopharmaceutic Sales by Application (2023-2028) & (Kiloton)
Table 65. North America Nuclear Medicine & Radiopharmaceutic Revenue by Application (2017-2022) & (US$ Million)
Table 66. North America Nuclear Medicine & Radiopharmaceutic Revenue by Application (2023-2028) & (US$ Million)
Table 67. North America Nuclear Medicine & Radiopharmaceutic Sales by Country (2017-2022) & (Kiloton)
Table 68. North America Nuclear Medicine & Radiopharmaceutic Sales by Country (2023-2028) & (Kiloton)
Table 69. North America Nuclear Medicine & Radiopharmaceutic Revenue by Country (2017-2022) & (US$ Million)
Table 70. North America Nuclear Medicine & Radiopharmaceutic Revenue by Country (2023-2028) & (US$ Million)
Table 71. Europe Nuclear Medicine & Radiopharmaceutic Sales by Company (2017-2022) & (Kiloton)
Table 72. Europe Nuclear Medicine & Radiopharmaceutic Sales Market Share by Company (2017-2022)
Table 73. Europe Nuclear Medicine & Radiopharmaceutic Revenue by Company (2017-2022) & (US$ Million)
Table 74. Europe Nuclear Medicine & Radiopharmaceutic Revenue Market Share by Company (2017-2022)
Table 75. Europe Nuclear Medicine & Radiopharmaceutic Sales by Type (2017-2022) & (Kiloton)
Table 76. Europe Nuclear Medicine & Radiopharmaceutic Sales by Type (2023-2028) & (Kiloton)
Table 77. Europe Nuclear Medicine & Radiopharmaceutic Revenue by Type (2017-2022) & (US$ Million)
Table 78. Europe Nuclear Medicine & Radiopharmaceutic Revenue by Type (2023-2028) & (US$ Million)
Table 79. Europe Nuclear Medicine & Radiopharmaceutic Sales by Application (2017-2022) & (Kiloton)
Table 80. Europe Nuclear Medicine & Radiopharmaceutic Sales by Application (2023-2028) & (Kiloton)
Table 81. Europe Nuclear Medicine & Radiopharmaceutic Revenue by Application (2017-2022) & (US$ Million)
Table 82. Europe Nuclear Medicine & Radiopharmaceutic Revenue by Application (2023-2028) & (US$ Million)
Table 83. Europe Nuclear Medicine & Radiopharmaceutic Sales by Country (2017-2022) & (Kiloton)
Table 84. Europe Nuclear Medicine & Radiopharmaceutic Sales by Country (2023-2028) & (Kiloton)
Table 85. Europe Nuclear Medicine & Radiopharmaceutic Revenue by Country (2017-2022) & (US$ Million)
Table 86. Europe Nuclear Medicine & Radiopharmaceutic Revenue by Country (2023-2028) & (US$ Million)
Table 87. Asia Pacific Nuclear Medicine & Radiopharmaceutic Sales by Company (2017-2022) & (Kiloton)
Table 88. Asia Pacific Nuclear Medicine & Radiopharmaceutic Sales Market Share by Company (2017-2022)
Table 89. Asia Pacific Nuclear Medicine & Radiopharmaceutic Revenue by Company (2017-2022) & (US$ Million)
Table 90. Asia Pacific Nuclear Medicine & Radiopharmaceutic Revenue Market Share by Company (2017-2022)
Table 91. Asia Pacific Nuclear Medicine & Radiopharmaceutic Sales by Type (2017-2022) & (Kiloton)
Table 92. Asia Pacific Nuclear Medicine & Radiopharmaceutic Sales by Type (2023-2028) & (Kiloton)
Table 93. Asia Pacific Nuclear Medicine & Radiopharmaceutic Revenue by Type (2017-2022) & (US$ Million)
Table 94. Asia Pacific Nuclear Medicine & Radiopharmaceutic Revenue by Type (2023-2028) & (US$ Million)
Table 95. Asia Pacific Nuclear Medicine & Radiopharmaceutic Sales by Application (2017-2022) & (Kiloton)
Table 96. Asia Pacific Nuclear Medicine & Radiopharmaceutic Sales by Application (2023-2028) & (Kiloton)
Table 97. Asia Pacific Nuclear Medicine & Radiopharmaceutic Revenue by Application (2017-2022) & (US$ Million)
Table 98. Asia Pacific Nuclear Medicine & Radiopharmaceutic Revenue by Application (2023-2028) & (US$ Million)
Table 99. Asia Pacific Nuclear Medicine & Radiopharmaceutic Sales by Region (2017-2022) & (Kiloton)
Table 100. Asia Pacific Nuclear Medicine & Radiopharmaceutic Sales by Region (2023-2028) & (Kiloton)
Table 101. Asia Pacific Nuclear Medicine & Radiopharmaceutic Revenue by Region (2017-2022) & (US$ Million)
Table 102. Asia Pacific Nuclear Medicine & Radiopharmaceutic Revenue by Region (2023-2028) & (US$ Million)
Table 103. Latin America Nuclear Medicine & Radiopharmaceutic Sales by Company (2017-2022) & (Kiloton)
Table 104. Latin America Nuclear Medicine & Radiopharmaceutic Sales Market Share by Company (2017-2022)
Table 105. Latin America Nuclear Medicine & Radiopharmaceutic Revenue by Company (2017-2022) & (US$ Million)
Table 106. Latin America Nuclear Medicine & Radiopharmaceutic Revenue Market Share by Company (2017-2022)
Table 107. Latin America Nuclear Medicine & Radiopharmaceutic Sales by Type (2017-2022) & (Kiloton)
Table 108. Latin America Nuclear Medicine & Radiopharmaceutic Sales by Type (2023-2028) & (Kiloton)
Table 109. Latin America Nuclear Medicine & Radiopharmaceutic Revenue by Type (2017-2022) & (US$ Million)
Table 110. Latin America Nuclear Medicine & Radiopharmaceutic Revenue by Type (2023-2028) & (US$ Million)
Table 111. Latin America Nuclear Medicine & Radiopharmaceutic Sales by Application (2017-2022) & (Kiloton)
Table 112. Latin America Nuclear Medicine & Radiopharmaceutic Sales by Application (2023-2028) & (Kiloton)
Table 113. Latin America Nuclear Medicine & Radiopharmaceutic Revenue by Application (2017-2022) & (US$ Million)
Table 114. Latin America Nuclear Medicine & Radiopharmaceutic Revenue by Application (2023-2028) & (US$ Million)
Table 115. Latin America Nuclear Medicine & Radiopharmaceutic Sales by Country (2017-2022) & (Kiloton)
Table 116. Latin America Nuclear Medicine & Radiopharmaceutic Sales by Country (2023-2028) & (Kiloton)
Table 117. Latin America Nuclear Medicine & Radiopharmaceutic Revenue by Country (2017-2022) & (US$ Million)
Table 118. Latin America Nuclear Medicine & Radiopharmaceutic Revenue by Country (2023-2028) & (US$ Million)
Table 119. Middle East and Africa Nuclear Medicine & Radiopharmaceutic Sales by Company (2017-2022) & (Kiloton)
Table 120. Middle East and Africa Nuclear Medicine & Radiopharmaceutic Sales Market Share by Company (2017-2022)
Table 121. Middle East and Africa Nuclear Medicine & Radiopharmaceutic Revenue by Company (2017-2022) & (US$ Million)
Table 122. Middle East and Africa Nuclear Medicine & Radiopharmaceutic Revenue Market Share by Company (2017-2022)
Table 123. Middle East and Africa Nuclear Medicine & Radiopharmaceutic Sales by Type (2017-2022) & (Kiloton)
Table 124. Middle East and Africa Nuclear Medicine & Radiopharmaceutic Sales by Type (2023-2028) & (Kiloton)
Table 125. Middle East and Africa Nuclear Medicine & Radiopharmaceutic Revenue by Type (2017-2022) & (US$ Million)
Table 126. Middle East and Africa Nuclear Medicine & Radiopharmaceutic Revenue by Type (2023-2028) & (US$ Million)
Table 127. Middle East and Africa Nuclear Medicine & Radiopharmaceutic Sales by Application (2017-2022) & (Kiloton)
Table 128. Middle East and Africa Nuclear Medicine & Radiopharmaceutic Sales by Application (2023-2028) & (Kiloton)
Table 129. Middle East and Africa Nuclear Medicine & Radiopharmaceutic Revenue by Application (2017-2022) & (US$ Million)
Table 130. Middle East and Africa Nuclear Medicine & Radiopharmaceutic Revenue by Application (2023-2028) & (US$ Million)
Table 131. Middle East and Africa Nuclear Medicine & Radiopharmaceutic Sales by Country (2017-2022) & (Kiloton)
Table 132. Middle East and Africa Nuclear Medicine & Radiopharmaceutic Sales by Country (2023-2028) & (Kiloton)
Table 133. Middle East and Africa Nuclear Medicine & Radiopharmaceutic Revenue by Country (2017-2022) & (US$ Million)
Table 134. Middle East and Africa Nuclear Medicine & Radiopharmaceutic Revenue by Country (2023-2028) & (US$ Million)
Table 135. GE Healthcare Corporation Information
Table 136. GE Healthcare Description and Overview
Table 137. GE Healthcare Nuclear Medicine & Radiopharmaceutic Sales (Kiloton), Revenue (US$ Million), Average Selling Price (ASP) (US$/Ton) and Gross Margin (2017-2022)
Table 138. GE Healthcare Nuclear Medicine & Radiopharmaceutic Product and Services
Table 139. GE Healthcare Nuclear Medicine & Radiopharmaceutic SWOT Analysis
Table 140. GE Healthcare Recent Developments
Table 141. Bracco Imaging Corporation Information
Table 142. Bracco Imaging Description and Overview
Table 143. Bracco Imaging Nuclear Medicine & Radiopharmaceutic Sales (Kiloton), Revenue (US$ Million), Average Selling Price (ASP) (US$/Ton) and Gross Margin (2017-2022)
Table 144. Bracco Imaging Nuclear Medicine & Radiopharmaceutic Product and Services
Table 145. Bracco Imaging Nuclear Medicine & Radiopharmaceutic SWOT Analysis
Table 146. Bracco Imaging Recent Developments
Table 147. Mallinckrodt Corporation Information
Table 148. Mallinckrodt Description and Overview
Table 149. Mallinckrodt Nuclear Medicine & Radiopharmaceutic Sales (Kiloton), Revenue (US$ Million), Average Selling Price (ASP) (US$/Ton) and Gross Margin (2017-2022)
Table 150. Mallinckrodt Nuclear Medicine & Radiopharmaceutic Product and Services
Table 151. Mallinckrodt Nuclear Medicine & Radiopharmaceutic SWOT Analysis
Table 152.